Coccidioidomycosis

Current Clinical Topics in Infectious Diseases

Volumn , Issue 17, 1997, Pages 188-204

  Galgiani, John N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; GAMMA INTERFERON; PYRROLE DERIVATIVE;

COCCIDIOIDOMYCOSIS; HUMAN; IMMUNOTHERAPY; REVIEW; UNITED STATES;

ANTIFUNGAL AGENTS; AZOLES; CALIFORNIA; COCCIDIOIDOMYCOSIS; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II;

EID: 0030628292     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (143)

1. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States. MMWR 1994;43:1-18.
2. Harrison WR, Merbs CF, Leathers CR. Evidence of coccidioidomycosis in the skeleton of an ancient Arizona Indian. J Infect Dis 1991;164:436-437.
3. Jones JL, Fleming PL, Ciesielski CA, et al. Coccidioidomycosis among persons with AIDS in the United States. J Infect Dis 1995;171:961-966.
4. Rush WL, Dooley DP, Blatt SP, Drehner DM. Coccidioidomycosis: a persistent threat to deployed populations. Aviat Space Environ Med 1993;64:653-657.
5. Bendel J. Valley fever strikes truckers. Truck News 1994;Feb:11-14.
6. Kirkland TN, Fierer J. Coccidioidomycosis: A re-emerging infectious disease. Emerging Infect Dis 1996;2:192-199.
7. Einstein HE, Johnson RH. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis 1993;16:349-356.
8. Stevens DA. Current concepts coccidioidomycosis. N Engl J Med 1995;332: 1077-1082.
9. Galgiani JN. Coccidioidomycosis. West J Med 1993;159:153-171.
10. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol 1988;2: 199-238.
11. Pappagianis D, Einstein H. Tempest from Tehachapi takes toll on coccidioides conveyed aloft and afar. West J Med 1978;129: 527-530.
12. Werner SB, Pappagianis D. Coccidioidomycosis in northern California. An outbreak among archeology students near Red Bluff. Calif Med 1973;119:10-20.
13. Werner SB, Pappagianis D, Heindl I, Mickel A. An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med 1972;286: 507-512.
14. Pappagianis D. Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin Infect Dis 1994;19:S14-S18.
15. Centers for Disease Control and Prevention. Coccidioidomycosis following the Northridge earthquake - California, 1994. MMWR 1994;43:194-195.
16. Centers for Disease Control (CDC). Coccidioidomycosis - Arizona, 1990-1995. MMWR 1996;45:1069-1073.
17. Jinadu BA. Valley Fever Task Force report on the control of Coccidioides immitis. 1995;••: ••. Abstract.
18. Smith CE, Beard RR, Rosenberger HG, Whiting EG. Effect of season and dust control on coccidioidomycosis. JAMA 1946;132: 833-838.
19. Caldwell JW, Welch G, Johnson RH, Einstein HE. The economic impact of coccidioidomycosis in Kern County, California, 1991-1993. In: Catanzaro A, Einstein HE, eds. Centennial Conference on Coccidioidomycosis. Proceedings of the Fourth International Conference on Coccidioidomycosis. Washington, DC: National Foundation for Infectious Diseases, 1996:88-97.
20. Standaert SM, Schaffner W, Galgiani JN, et al. Coccidioidomycosis among visitors to a Coccidioides immitis-endemic area: an out-break in a military reserve unit. J Infect Dis 1995;171:1672-1675.
21. Sekhon AS, Isaac-Renton J, Dixon JM, et al. Review of human and animal cases of coccidioidomycosis diagnosed in Canada. Mycopathologia 1991;113:1-10.
22. Muir S, Pappagianis D. Coccidioidomycosis in the Ilama: case report and epidemiologic survey. J Am Vet Med Assoc 1982;181:1334-1337.
23. Millman TM, O'Brien TR, Sutter PF, Wolf AM. Coccidioidomycosis in the dog: its radio-graphic diagnosis. Am J Vet Radiol 1992;20: 50-65.
24. Greene RT, Troy GC. Coccidioidomycosis in 48 cats: a retrospective study (1984-1993). J Vet Intern Med 1995;9:86-91.
25. Huppert M, Sun SH, Harrison JL. Morphogenesis throughout saprobic and parasitic cycles of Coccidioides immitis. Mycopathologia 1982;78:107-122.
26. Sun SH, Cole GT, Drutz DJ, Harrison JL. Electron-microscopic observations of the Coccidioides immitis parasitic cycle in vivo. J Med Vet Mycol 1986;24:183-192.
27. de la Maza LM. Coccidioides immitis. N Engl J Med 1993;329:1935.
28. Wages DS, Helfend L, Finkle H. Coccidioides immitis presenting as a hyphal form in a ventriculoperitoneal shunt. Arch Pathol Lab Med 1995;119:91-93.
29. Burt A, Carter DA, Koenig GL, et al. Molecular markers reveal cryptic sex in the human pathogen Coccidioides immitis. Proc Natl Acad Sci USA 1996;93:770-773.
30. Bowman BH, Taylor JW, Brownlee AG, et al. Molecular evolution of the fungi: relationship of the basidiomycetes, ascomycetes, and chytridiomycetes. Mol Biol Evol 1992;9:285-296.
31. Bowman BH, Taylor JW, White TJ. Molecular evolution of the fungi: human pathogens. Mol Biol Evol 1992;9:893-904.
32. Bowman BH, White TJ, Taylor JW. Evolutionary relationships of human pathogenic fungi: multiple origins of pathogenicity in the fungal order Onygenales. Molec Phylog Evol 1996;6:89-96.
33. Pan S, Sigler L, Cole GT. Evidence for a phylogenetic connection between Coccidioides immitis and Uncinocarpus reesii (Onygenaceae). J Gen Microbiol 1994;140: 1481-1494.
34. Lundergan LL, Kerrick SS, Galgiani JN. Coccidioidomycosis at a university outpatient clinic: a clinical description. In: Einstein HE, Catanzaro A, eds. Coccidioidomycosis. Proceedings of the Fourth International Conference. Washington, DC: National Foundation for Infectious Diseases, 1985:47-54.
35. Yozwiak ML, Lundergan LL, Kerrick SS, Galgiani JN. Symptoms and routine laboratory abnormalities associated with coccidioidomycosis. West J Med 1988;149: 419-421.
36. Kerrick SS, Lundergan LL, Galgiani JN. Coccidioidomycosis at a university health service. Am Rev Respir Dis 1985;131:100-102.
37. Ragland AS, Arsura EL, Ismail Y, Johnson R. Eosinophilic pleocytosis in coccidioidal meningitis: frequency and significance. Am J Med 1993;95:154-157.
38. Harley WB, Blaser MJ. Disseminated coccidioidomycosis associated with extreme eosinophilia. Clin Infect Dis 1994;18:627-629.
39. Lopez AM, Williams PL, Ampel NM. Acute pulmonary coccidioidomycosis mimicking bacterial pneumonia and septic shock: a report of two cases. Am J Med 1993;95:236-239.
40. Westphal SA, Sarosi GA. Diabetic ketoacidosis associated with pulmonary coccidioidomycosis. Clin Infect Dis 1994;18:974-978.
41. Moorthy RS, Rao NA, Sidikaro Y, Foos RY. Coccidioidomycosis iridocyclitis. Ophthalmology 1994;101:1923-1928.
42. Rodenbiker HT, Ganley JP. Ocular coccidioidomycosis. Surv Ophthalmol 1980; 24:263-290.
43. Braun RA, Buchmiller TL, Khankhanian N. Pulmonary arteriovenous malformation complicating coccidioidal pneumonia. Ann Thorac Surg 1995;60:454-457.
44. Richardson V, Valenciano-Vega JI, Valenzuela-Espinoza A. Bronchoesophageal fistulas secondary to coccidioidomycosis. Pediatr Infect Dis J 1994;13:159-161.
45. Primack SL, Hartman TE, Soo Lee K, Müller NL. Pulmonary nodules and the CT halo sign. Radiology 1994;190:513-515.
46. Forseth J, Rohwedder JJ, Levine BE, Saubolle MA. Experience with needle biopsy for coccidioidal lung nodules. Arch Intern Med 1986;146:319-320.
47. Swensen SJ, Jett JR, Payne WS, et al. An integrated approach to evaluation of the solitary pulmonary nodule. Mayo Clin Proc 1990;65:173-186.
48. Zwirewich CV, Vadal S, Miller RR, Müller NL. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology 1991;179:469-476.
49. Winn RE, Johnson R, Galgiani JN, et al. Cavitary coccidioidomycosis with fungus ball formation: diagnosis by fiberoptic bronchoscopy with coexistence of hyphae and spherules. Chest 1994;105:412-416.
50. Nardell EA. A 20-year-old man with recurrent hemoptysis and a pulmonary cavity. N Engl J Med 1994;330:1516-1522.
51. Winn WA. A long term study of 300 patients with cavitary abscess lesions of the lung of coccidioidal origin. Chest 1968;54:S12-S16.
52. Cunningham RT, Einstein H. Coccidioidal pulmonary cavities with rupture. J Thorac Cardiovasc Surg 1982;84:172-177.
53. Peterson CM, Schuppert K, Kelly PC, Pappagianis D. Coccidioidomycosis and pregnancy. Obstet Gynecol Surv 1993;48: 149-156.
54. Stone JL, Kalina RE. Ocular coccidioidomycosis. Am J Ophthalmol 1993;116: 249-250.
55. Amundson DE. Perplexing pericarditis caused by coccidioidomycosis. South Med J 1993;86:694-696.
56. Smith MA, Anderson AE, Kostroff K. An unusual case of coccidioidomycosis. J Clin Microbiol 1994;32:1063-1064.
57. Hicks MJ, Green LK, Clarridge J. Primary diagnosis of disseminated coccidioidomycosis by fine needle aspiration of a neck mass: a case report. Acta Cytol 1994;38:422-426.
58. Banuelos AF, Williams PL, Johnson RH, et al. Central Nervous system abscesses due to Coccidioides immitis. Clin Infect Dis 1996;22:240-250.
59. Kushwaha VP, Shawn BA, Gerardi JD. Coccidioidomycosis - A review of 25 cases. Clin Orthoped 1996;332:190-199.
60. Vincent T, Galgiani JN, Huppert M, Salkin D. The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955-1958. Clin Infect Dis 1993;16:247-254.
61. Labadie EL, Hamilton RH. Survival improvement in coccidioidal meningitis by high-dose intrathecal amphoteriein B. Arch Intern Med 1986;146:2013-2018.
62. Pappagianis D, Crane R. Survival in coccidioidal meningitis since introduction of Amphotericin B. In: Ajello L, ed. Coccidioidomycosis. Current clinical and diagnostic status. Miami: Symposia Specialists, 1977:223-237.
63. Einstein HE, Holeman CW Jr, Sandidge LL, Holden DH. Coccidioidal meningitis. The use of amphotericin B in treatment. Calif Med 1961;94:339-343.
64. Mischel PS, Vinters HV. Coccidioidomycosis of the central nervous system: neuropathological and vasculopathic manifestations and clinical correlates. Clin Infect Dis 1995;20:400-405.
65. Reef SE, Galgiani JN, Hutwagner L, et al. Natural history of disseminated coccidioidomycosis. Analysis of Armed Forces-VA collaborative study group records, 1955-1958. Presented at Centennial Conference on Coccidioidomycosis, 1994:51. Abstract.
66. Deresinski SC, Stevens DA. Coccidioidomycosis in compromised hosts. Experience at Stanford University Hospital. Medicine (Baltimore) 1974;54:377-395.
67. Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med 1982;142: 489-494.
68. Riley DK, Galgiani JN, O'Donnell MR, et al. Coccidioidomycosis in bone marrow transplant recipients. Transplantation 1994;56: 1531-1533.
69. Dodd LG, Nelson SD. Disseminated coccidioidomycosis detected by percutaneous liver biopsy in a liver transplant recipient. Am J Clin Pathol 1990;93:141-144.
70. Vartivarian SE, Coudron PE, Markowitz SM. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med 1987;83:949-952.
71. Hall KA, Copeland JG, Zukoski CF, et al. Markers of coccidioidomycosis before cardiac or renal transplantation and the risk of recurrent infection. Transplantation 1993;55: 1422-1424.
72. Calhoun DL, Galgiani JN, Cukowski C, Copeland JG. Coccidioidomycosis in recent renal or cardiac transplant recipients. In: Einstein HE, Catanzaro A, eds. Coccidioidomycosis. Proceedings of the Fourth International Conference on Coccidioidomycosis. Washington, DC: National Foundation for Infectious Diseases, 1985:312-318.
73. Hall KA, Sethi GK, Rosado LJ, et al. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 1993;12:525-526.
74. McCarthy M. US guidelines on fungal infections and HIV infection. Lancet 1995;346: 630.
75. McNeil MM, Ampel NM. Opportunistic Coccidioidomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis 1995; 21(suppl. 1):S111-S113.
76. Huth RG. Concomitant systemic cryptococcosis and Coccidioidomycosis in a patient with AIDS. Clin Infect Dis 1994;18:262-263.
77. Ampel NM, Dois CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection. Results of a prospective study in a coccidioidal endemic area. Am J Med 1993;94:235-240.
78. Mahaffey KW, Hippenmeyer CL, Mandel R, Ampel NM. Unrecognized Coccidioidomycosis complicating Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus and treated with corticosteroids: a report of two cases. Arch Intern Med 1993;153:1496-1498.
79. Jamidar PA, Campbell DR, Fishback JL, Klotz SA. Peritoneal Coccidioidomycosis associated with human immunodeficiency virus infection. Gastroenterology 1992;102:1054-1058.
80. Antoniskis D, Larsen RA, Akil B, et al. Seronegative disseminated Coccidioidomycosis in patients with HIV infection. AIDS 1990;4:691-693.
81. Galgiani JN, Ampel NM. Coccidioidomycosis in human immunodeficiency virus-infected patients. J Infect Dis 1990; 162:1165-1169.
82. Bronnimann DA, Adam RD, Galgiani JN, et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:372-379.
83. Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) 1990;69: 384-391.
84. Ampel NM, Ryan KJ, Carry PJ, et al. Fungemia due to Coccidioides immitis. An analysis of 16 episodes in 15 patients and a review of the literature. Medicine (Baltimore) 1986;65:312-321.
85. Singh VR, Smith DK, Lawrence J, et al. Coccidioidomycosis in patients infected with the human immunodeficiency virus: Review of 91 cases at a single institution. Clin Infect Dis 1996;23:563-568.
86. Shawar RM, Salyer JL, Ballou D, Clarridge JE. Recovery of Coccidioides immitis from blood and abscess fluid using the BacT/Alcrt system. Diagn Microbiol Infect Dis 1995;21: 15-19.
87. DiTomasso JP, Ampel NM, Sobonya RE, Bloom JW. Bronchoscopic diagnosis of pulmonary Coccidioidomycosis: comparison of ecology, culture, and transbronchial biopsy. Diagn Microbiol Infect Dis 1994;18:83-87.
88. Sun SH, Huppert M, Vukovich KR. Rapid in vitro conversion and identification of Coccidioides immitis. J Clin Microbiol 1976; 3:186-190.
89. Huppert M, Sun SH, Rice EH. Specificity of exoantigens for identifying cultures of Coccidioides immitis. J Clin Microbiol 1978;8:346-348.
90. Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995;33:2913-2919.
91. Beard JS, Benson PM, Skillman L. Rapid diagnosis of Coccidioidomycosis with a DNA probe to ribosomal RNA. Arch Dermatol 1993;129:1589-1593.
92. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev 1990;3:247-268.
93. Smith CE, Saito MT, Simons SA. Pattern of 39,500 serologic tests in coccidioidomycosis. JAMA 1956;160:546-552.
94. Johnson SM, Pappagianis D. The coccidioidal complement fixation and immunodiffusion-complement fixation antigen is a chitinase. Infect Immun 1992;60: 2588-2592.
95. Johnson SM, Zimmermann CR, Pappagianis D. Amino-terminal sequence analysis of the Coccidioides immitis chitinase/ immunodiffusion-complement fixation protein. Infect Immun 1993;61:3090-3092.
96. Yang CM, Zhu YF, Magee DM, Cox RA. Molecular cloning and characterization of the Coccidioides immitis complement fixation chitinasc antigen. Infect Immun 1996;64:1992-1997.
97. Pishko EJ, Kirkland TN, Cole GT. Isolation and characterization of two chitinase-encoding genes (cts1, cts2) from the fungus Coccidioides immitis. Gene 1995;167:173-177.
98. Zimmermann CR, Johnson SM, Martens GW, White AG, Pappagianis D. Cloning and expression of the complement fixation antigen-chitinase of Coccidioides immitis. Infect Immun 1996;64:4967-4975.
99. Gade W, Ledman DW, Wellington R, Yi A. Serological responses to various Coccidioides antigen preparations in a new enzyme immunoassay. J Clin Microbiol 1992;30: 1907-1912.
100. Martins TB, Jaskowski TD, Mouritsen CL, Hill HR Comparison of commercially available enzyme immunoassay with traditional serological tests for detection of antibodies to Coccidioides immitis. J Clin Microbiol 1995; 33:940-943.
101. Kaufman L, Sekhon AS, Moledina N, et al. Comparative evaluation of commercial premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J Clin Microbiol 1995; 33:618-619.
102. Wieden MA, Lundergan LL, Blum J, et al. Detection of coccidioidal antibodies by 33-kDa spherule antigen, Coccidioides EIA, and standard serologic tests in sera from patients evaluated for coccidioidomycosis. J Infect Dis 1996;173:1273-1277.
103. Dugger KO, Villareal KM, Ngyuen A, et al. Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential. Biochem Biophys Res Commun 1996;218:485-489.
104. Yoshinoya S, Cox RA, Pope RM. Circulating immune complexes in coccidioidomycosis. Detection and characterization. J Clin Invest 1980;66:655-663.
105. Galgiani JN, Ito JI, Dugger KO. Enzyme-linked immunosorbent assay detection of coccidioidal antigens in human serum. In: Einstein HE, Catanzaro A, eds. Coccidioidomycosis. Proceedings of the Fourth International Conference on Coccidioidomycosis. Washington, DC: National Foundation of Infectious Diseases, 1985:239-249.
106. Galgiani JN, Grace GM, Lundergan LL. New serologic tests for early detection of coccidioidomycosis. J Infect Dis 1991;163: 671-674.
107. Weiner MH. Antigenemia detected in human coccidioidomycosis. J Clin Microbiol 1983;18:136-142.
108. Klager KJ, Knoper SR, Bloom JW. PCR amplification of the 18S rRNA gene from Coccidioides immitis DNA. Presented at ATS International Conference, May 21-24 1995. Abstract.
109. Graybill JR, Lundberg D, Donovan W, et al. Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients. Rev Infect Dis 1980;2:661-673.
110. Defelice R, Galgiani JN, Campbell SC, et al. Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study. Am J Med 1982;72:681-687.
111. Craven PC, Graybill JR, Jorgensen JH, et al. High-dose ketoconazole for treatment of fungal infections of the central nervous system. Ann Intern Med 1983;98:160-167.
112. Galgiani JN. Ketoconazole in the treatment of coccidioidomycosis. Drugs 1983;26:355-363.
113. Galgiani JN, Stevens DA, Graybill JR, et al. Ketoconazole therapy of progressive coccidioidomycosis. Comparison of 400- and 800-mg doses and observations at higher doses. Am J Med 1988;84:603-610.
114. Catanzaro A, Einstein H, Levine B, et al. Ketoconazole for treatment of disseminated coccidioidomycosis. Ann Intern Med 1982;96:436-440.
115. Diaz M, Puente R, De Hoyos LA, Cruz S. Itraconazole in the treatment of coccidioidomycosis. Chest 1991;100:682-684.
116. Stevens DA. Itraconazole and fluconazole for treatment of coccidioidomycosis. Clin Infect Dis 1994;18:470.
117. Tucker RM, Denning DW, Dupont B, Stevens DA. Itraconazole therapy for chronic coccidioidal meningitis. Ann Intern Med 1990;112:108-112.
118. Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis.Am J Med 1995;98:249-256.
119. Catanzaro A, Fierer J, Friedman PJ. Fluconazole in the treatment of persistent coccidioidomycosis. Chest 1990;97:666-669.
120. Tucker RM, Galgiani JN, Denning DW, et al. Treatment of coccidioidal meningitis with fluconazole. Rev Infect Dis 1990;12(suppl 3): S380-S389.
121. Galgiani JN, Catanzaro A, Cloud GA, et al. Fluconazole therapy for coccidioidal meningitis. Ann Intern Med 1993;119:28-35.
122. Graybill JR, Stevens DA, Galgiani JN, et al. Itraconazole treatment of coccidioidomycosis. Am J Med 1990;89:282-290.
123. Tucker RM, Denning DW, Arathoon EG, et al. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations. J Am Acad Dermatol 1990;23 (suppl):593-601.
124. Schwartz DN, Fihn SD, Miller RA. Infection of an arterial prosthesis as the presenting manifestation of disseminated coccidioidomycosis: control of disease with fluconazole. Clin Infect Dis 1993;16:486-488.
125. Luttrull JK, Wan WL, Kubak BM, et al. Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol 1995; 119:477-481.
126. Pappas PG, Kauffman CA, Perfect J, et al. Alopecia associated with fluconazole therapy. Ann Intern Med 1995;123:354-357.
127. Garvin GJ, Peterfy CG. Soft tissue coccidioidomycosis on MRI. J Comput Assist Tomogr 1995;19:612-614.
128. Arguinchona HL, Ampel NM, Dois CL, et al. Persistent coccidioidal seropositivity without clinical evidence of active coccidioidomycosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1995;20:1281-1285.
129. Pérez JA Jr, Johnson RH, Caldwell JW, et al. Fluconazole therapy in coccidioidal meningitis maintained with intrathccal amphotericin B. Arch Intern Med 1995;155: 1665-1668.
130. Dewsnup DH, Galgiani JN, Graybill JR, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med 1996;124:305-310.
131. Fiedler H-P, Schuz T, Decker H. An overview of nikkomycins: history, biochemistry, and applications. In: Rippon JW, Fromtling RA, eds. Cutaneous antifungal agents: selected compounds in clinical practice and development. New York: Marcel Dekker, 1993:325-352.
132. Cabib E. Differential inhibition of chitin synthetases 1 and 2 from Saccharomyces cerevisiae by polyoxin D and nikkomycins. Antimicrob Agents Chemother 1991;35:170-173.
133. Hector RF, Zimmer BL, Pappagianis D. Inhibitors of cell wall synthesis. Nikkomycins. In: Yamaguchi H, Kobayashi GS, Takahashi H, eds. Recent progress in antifungal chemotherapy. New York: Marcel Dekker, 1991: 341-353.
134. Hector RF, Zimmer BL, Pappagianis D. Evaluation of niklcomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother 1990;34:587-593.
135. Debono M, Gordee RS. Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol 1994;48:471-497.
136. Galgiani JN, Sun SH, demons KV, Stevens DA. Activity of cilofungin against Coccidioides immitis: differential in vitro effects on mycelia and spherules correlated with in vivo studies. J Infect Dis 1990;162:944-948.
137. Beaman L. Fungicidal activation of murine macrophages by recombinant gamma interferon. Infect Immun 1987;55:2951-2955.
138. Beaman L. Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Coccidioides immitis. Infect Immun 1991;59:4227-4229.
139. Magee DM, Cox RA. Roles of gamma interferon and intcrleukin-4 in genetically determined resistance to Coccidioides immitis. Infect Immun 1995;63:3514-3519.
140. + T cells during initiation of infection. J Exp Med 1994;179:447-456.
141. Gazzinelli RT, Wysocka M, Hayashi S, et al. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 1994;153:2533-2543.
142. Zhou P, Sieve MC, Bennett J, et al. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol 1995;155:785-795.
143. Pappagianis D, Valley Fever Vaccine Study Group. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am Rev Respir Dis 1993;148:656-660.